20:38:15 Europe / Stockholm
2024-05-16 08:30:00

Calliditas's interim report for the first quarter, January - March 2024 will be published in Swedish and English on Thursday 23 May 2024 at 07.00 a.m. CET.

A combined audio cast and telephone conference with the opportunity to ask questions will be held at 14.30 p.m. CET on the same day, with CEO Renée Aguiar-Lucander and CFO Fredrik Johansson, CMO Richard Philipson and President North America Maria Törnsén.

The presentation will be given in English.

Link to the webcast: 

Calliditas Therapeutics Q1 Report 2024 (financialhearings.com) (https://ir.financialhearings.com/calliditas-therapeutics-q1-report-2024)

To participate via conference call please register via this link: https://conference.financialhearings.com/teleconference/?id=50047214

After registration, you will receive a phone number and a conference ID to log in to the conference call. Via the telephone conference, there is an opportunity to ask oral questions.